BAG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.833000E-01
Normal-vs-Stage2
8.478400E-01
Normal-vs-Stage3
7.080200E-01
Normal-vs-Stage4
4.276200E-01
Stage1-vs-Stage2
8.030400E-01
Stage1-vs-Stage3
6.772600E-01
Stage1-vs-Stage4
4.338000E-01
Stage2-vs-Stage3
8.939400E-01
Stage2-vs-Stage4
7.278400E-01
Stage3-vs-Stage4
7.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.207200E-01
Normal-vs-AfricanAmerican
9.377600E-01
Normal-vs-Asian
9.284800E-01
Caucasian-vs-AfricanAmerican
5.398200E-01
Caucasian-vs-Asian
8.709600E-01
AfricanAmerican-vs-Asian
9.053400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.387600E-01
Normal-vs-Female
8.168400E-01
Male-vs-Female
9.286200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.242000E-01
Normal-vs-Age(41-60Yrs)
6.785200E-01
Normal-vs-Age(61-80Yrs)
8.724800E-01
Normal-vs-Age(81-100Yrs)
9.580800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.791000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.879400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.236400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.007800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.820800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.394600E-01
Normal-vs-Daily Drinker
3.115400E-01
Normal-vs-Weekly Drinker
6.293000E-01
Normal-vs-Occasional Drinker
8.847800E-01
Normal-vs-Social Drinker
6.446200E-01
Non Drinker-vs-Daily Drinker
6.860200E-01
Non Drinker-vs-Weekly Drinker
1.196750E-01
Non Drinker-vs-Occasional Drinker
1.471620E-01
Non Drinker-vs-Social Drinker
1.673970E-01
Daily Drinker-vs-Weekly Drinker
8.762100E-02
Daily Drinker-vs-Occasional Drinker
8.777500E-02
Daily Drinker-vs-Social Drinker
1.396040E-01
Weekly Drinker-vs-Occasional Drinker
4.169200E-01
Weekly Drinker-vs-Social Drinker
7.586200E-01
Occasional Drinker-vs-Social Drinker
3.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.978000E-01
Normal-vs-Grade 2
6.540000E-01
Normal-vs-Grade 3
8.024000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.885600E-01
Grade 1-vs-Grade 3
3.664000E-01
Grade 1-vs-Grade 4
6.978000E-01
Grade 2-vs-Grade 3
1.087160E-01
Grade 2-vs-Grade 4
6.540000E-01
Grade 3-vs-Grade 4
8.024000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.150600E-01
Normal-vs-NonDiabetic
9.745200E-01
Diabetic-vs-NonDiabetic
1.888830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.211600E-01
Normal-vs-NoPancreatitis
9.526200E-01
Pancreatitis-vs-NoPancreatitis
4.958200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.276800E-01
Normal-vs-N1
8.347600E-01
N0-vs-N1
5.650200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.175200E-01
Normal-vs-TP53-NonMutant
9.090400E-01
TP53-Mutant-vs-TP53-NonMutant
6.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
